Rabies Vaccine Market: Current Analysis and Forecast (2022-2030)
Emphasis on Product Type (Vero Cell Rabies Vaccine, Baby Hamster Kidney (BHK), Chick Embryo Cell Rabies Vaccine, and Others); Application (Pre-Exposure Prophylaxis and Post-Exposure Prophylaxis); Distribution Channel (Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy); and Region/Country
The Rabies Vaccine market was valued at USD 14400 Mn and is expected to grow at a strong CAGR of around 5% during the forecast period (2022-2030). The Rabies Vaccine is a vaccine that is used to prevent Rabies, a viral infection that can be fatal if left untreated. The vaccine is typically given to people who have been bitten or scratched by an animal that may have rabies, as well as to people who work with animals or who are at a higher risk of exposure to the virus. As people become more health-conscious, there is an increasing demand for preventive healthcare products, including vaccines. Rabies vaccines are an important component of preventive healthcare, and the growing demand for these products is driving the rabies vaccine market.
Some of the major players operating in the market are Serum Institute of India Pvt. Ltd.; Novartis AG; Cadila Pharmaceuticals; Merck & Co., Inc.; Sanofi; Berna Biotech Pharma GmbH.; AstraZeneca.; Boehringer Ingelheim International GmbH; Elanco; and Zoetis Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.
Insights Presented in the Report
“Amongst product type, the vero cell rabies vaccine segment is expected to grow at a higher CAGR during the forecast period.”
Based on product type, the market is segmented into vero cell rabies vaccine, baby hamster kidney (BHK), chick embryo cell rabies vaccine, and others. As per our analysis, the vero cell rabies vaccine segment is expected to grow at a higher CAGR during the forecast period. The Vero cell technology involves growing the rabies virus in specialized cells, which results in a more stable and consistent vaccine. The Veo Cell Rabies Vaccine is approved for use in adults and children and is widely used in many countries around the world. These are the important factors driving the growth of the segment.
“Amongst application, the post-prophylaxis segment held the dominant share in 2021.”
Based on the application, the market is segmented into pre-exposure prophylaxis and post-exposure prophylaxis. As per our analysis, the pharmaceutical segment held the dominant share in 2021. Post-exposure prophylaxis (PEP) is a preventive treatment used to protect individuals who may have been exposed to the rabies virus. PEP involves a series of injections with a rabies vaccine and, in some cases, the administration of rabies immunoglobulin (RIG). These vaccines are generally considered safe and effective in preventing rabies if administered according to the recommended schedule. It’s worth noting that the availability and specific market dynamics of PEP rabies vaccines can change over time.
Rabies Vaccine Market Report Coverage
“Amongst distribution channels, the online pharmacy segment is expected to grow at a higher CAGR during the forecast period.”
Based on the distribution channel, the market is segmented into hospital pharmacy, online pharmacy, and retail pharmacy. As per our analysis, the online pharmacy segment is expected to grow at a higher CAGR during the forecast period. The increasing internet adoption, along with the rising integration of internet-based systems in hospitals for better patient experience attributes to the growth of the segment.
“Asia Pacific is expected to grow with the highest CAGR Rabies Vaccine market during the forecast period.”
Asia Pacific is expected to grow with the highest CAGR Rabies Vaccine market during the forecast period due to due to the high prevalence of rabies in several countries within the region. Rabies is a significant public health concern in many Asian countries, particularly in rural areas where exposure to rabid animals is more common. Government initiatives and public health campaigns play a crucial role in raising awareness about rabies and promoting vaccination programs. In many countries, especially those with a higher incidence of rabies, efforts are made to improve access to vaccines, educate the public about the importance of vaccination, and implement effective control measures to prevent the spread of the disease.
Reasons to buy this report:
- The study includes market sizing and forecasting analysis validated by authenticated key industry experts.
- The report presents a quick review of overall industry performance at one glance.
- The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolios, expansion strategies, and recent developments.
- Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.
- The study comprehensively covers the market across different segments.
- Deep dive regional level analysis of the industry.
Customization Options:
The global rabies vaccine market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.
Table of Contents
Research Methodology for the Rabies Vaccine Market Analysis (2022-2030)
Analyzing the historical market, estimating the current market, and forecasting the future market of the global Rabies Vaccine market were the three major steps undertaken to create and analyze the adoption of Rabies Vaccines in major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the global Rabies Vaccine market. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments of the industry pertains to. Detailed methodology is explained below:
Analysis of Historical Market Size
Step 1: In-Depth Study of Secondary Sources:
Detail secondary study was conducted to obtain the historical market size of the Rabies Vaccine market through company internal sources such as annual reports & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.
Step 2: Market Segmentation:
After obtaining the historical market size of the Rabies Vaccine market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments are included in the report as type and end-use. Further country-level analyses were conducted to evaluate the overall adoption of testing models in that region.
Step 3: Factor Analysis:
After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of the Rabies Vaccine market. Further, we conducted factor analysis using dependent and independent variables such as type and end-use of the Rabies Vaccine market. A thorough analysis was conducted for demand and supply-side scenarios considering top partnerships, mergers and acquisitions, business expansion, and product launches in the Rabies Vaccine market sector across the globe.
Current Market Size Estimate & Forecast
Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the global Rabies Vaccine market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.
Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., the top-down/bottom-up approach were applied to arrive at the market forecast for 2030 for different segments and sub-segments across the major markets globally. The research methodology adopted to estimate the market size encompasses:
- The industry’s market size, in terms of revenue (USD) and the adoption rate of the Rabies Vaccine market across the major markets domestically
- All percentage shares, splits, and breakdowns of market segments and sub-segments
- Key players in the global Rabies Vaccine market in terms of products offered. Also, the growth strategies adopted by these players to compete in the fast-growing market
Market Size and Share Validation
Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.
Split of Primary Participants in Different Regions
Market Engineering
The data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers for each segment and sub-segment of the global Rabies Vaccine market. data was split into several segments & sub-segments post studying various parameters and trends in the areas of the type, category, and application in the global Rabies Vaccine market.
The main objective of the Global Rabies Vaccine Market Study
The current & future market trends of the global Rabies Vaccine market were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments on the qualitative and quantitative analysis performed in the study. Current and future market trends determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit from a first-mover advantage. Other quantitative goals of the studies include:
- Analyze the current and forecast market size of the Rabies Vaccine market in terms of value (USD). Also, analyze the current and forecast market size of different segments and sub-segments
- Segments in the study include areas of type and end-use.
- Define and analysis of the regulatory framework for the Rabies Vaccine industry
- Analyze the value chain involved with the presence of various intermediaries, along with analyzing customer and competitor behaviors of the industry
- Analyze the current and forecast market size of the Rabies Vaccine market for the major region
- Major countries of regions studied in the report include Asia Pacific, Europe, North America, and the Rest of the World
- Company profiles of the Rabies Vaccine market and the growth strategies adopted by the market players to sustain in the fast-growing market
- Deep dive regional level analysis of the industry
Related Reports
Customers who bought this item also bought
Antibiotic Resistance Market: Current Analysis and Forecast (2024-2032)
Emphasis on Disease Type (Urinary Tract Infections, Intra-Abdominal Infections, Blood Stream Infections, Clostridium Difficile Infections, And Others); Pathogen Type (Acinetobacter baumannii, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pneumoniae, and Others); Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, and Others); and Region/Country
October 8, 2024
